Ticker
ANABCompany Name
ANAPTYSBIO INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Cash Return on Invested Capital | Free Cash Flow | Invested Capital |
---|---|---|---|
6/30/2025 | -42.45% | $ -128.08M | $ 301.72M |
3/31/2025 | -28.73% | $ -109.15M | $ 379.98M |
12/31/2024 | -30.82% | $ -135.69M | $ 440.33M |
9/30/2024 | -22.9% | $ -103.39M | $ 451.43M |
6/30/2024 | -33.41% | $ -129.9M | $ 388.81M |
3/31/2024 | -35.74% | $ -134.14M | $ 375.35M |
12/31/2023 | -29.18% | $ -121.61M | $ 416.72M |
9/30/2023 | -21.75% | $ -97.84M | $ 449.89M |
6/30/2023 | -16.56% | $ -79M | $ 477.18M |
3/31/2023 | -15% | $ -77.63M | $ 517.67M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
FCF / Inv. Capital
(=) CROIC
CROIC for ANAPTYSBIO INC is calculated as follows: FCF [ $ -67.9M ] / Inv. Capital [ $ 360.24M ]
(=) CROIC [ -18.85% ]
Minimum
Jun 30, 2025
Maximum
Sep 30, 2021
Average
Median
filtered constituents | 3.46K |
---|---|
min | -43.78% |
max | 49.3% |
average | 2.78% |
median | 4.97% |
std | 15.05% |